(Q31805491)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142573%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Lansoprazole in the treatment of gastro-oesophageal reflux disease in childhood (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142573%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142573%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

M T Franco

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142573%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

G Salvia

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142573%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

R Spadaro

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142573%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

I De Rosa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142573%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

V D Iula

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142573%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

S Cucchiara

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142573%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 November 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142573%20AND%20SRC:MED&resulttype=core&format=json

Digestive and Liver Disease

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142573%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142573%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142573%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

660-666

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142573%20AND%20SRC:MED&resulttype=core&format=json

Gastroesophageal reflux disease in children

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980326-6

7 January 2021

Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980326-6

7 January 2021

Do H2 receptor antagonists have a therapeutic role in childhood?

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980326-6

7 January 2021

Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980326-6

7 January 2021

Lansoprazole versus ranitidine in the maintenance treatment of reflux oesophagitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980326-6

7 January 2021

Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980326-6

7 January 2021

Efficacy and safety of omeprazole for severe gastroesophageal reflux in children.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980326-6

7 January 2021

Effect of omeprazole in the treatment of refractory acid-related diseases in childhood: endoscopic healing and twenty-four-hour intragastric acidity

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980326-6

7 January 2021

Histological esophagitis: clinical and histological response to omeprazole in children

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980326-6

7 January 2021

Omerprazole and other proton pump inhibitors: pharmacology, efficacy, and safety, with special reference to use in children

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980326-6

7 January 2021

Peptic strictures of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980326-6

7 January 2021

Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980326-6

7 January 2021

Appropriate acid suppression for the management of gastro-oesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980326-6

7 January 2021

Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980326-6

7 January 2021

Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980326-6

7 January 2021

Statement of the North American Society for Pediatric Gastroenterology and Nutrition (NASPGN). Indications for pediatric esophageal pH monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980326-6

7 January 2021

Oesophageal disorders and gastro-oesophageal reflux disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980326-6

7 January 2021

Oesophageal motor function before and after healing of oesophagitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980326-6

7 January 2021

Esophageal peristaltic dysfunction in peptic esophagitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980326-6

7 January 2021

Effects of omeprazole on mechanisms of gastroesophageal reflux in childhood.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980326-6

7 January 2021

Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980326-6

7 January 2021

Omeprazole or ranitidine in long-term treatment of reflux esophagitis. The Scandinavian Clinics for United Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980326-6

7 January 2021

The safety of omeprazole: true or false?

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980326-6

7 January 2021

Safety profile of Lansoprazole: the US clinical trial experience

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980326-6

7 January 2021

Antireflux surgery in children: time for a harder look

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980326-6

7 January 2021

10.1016/S1590-8658(00)80326-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11142573%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference